Literature DB >> 27021019

Human Glutathione S-Transferase Enzyme Gene Polymorphisms and Their Association With Neurocysticercosis.

Amrita Singh1, Kashi N Prasad2, Aloukick K Singh1, Satyendra K Singh1, Kamlesh K Gupta1, Vimal K Paliwal3, Chandra M Pandey4, Rakesh K Gupta5.   

Abstract

Neurocysticercosis (NCC), caused by cysticerci of Taenia solium is the most common helminthic infection of the central nervous system. Some individuals harboring different stages of cysticerci in the brain remain asymptomatic, while others with similar cysticerci lesions develop symptoms and the reasons remain largely unknown. Inflammatory response to antigens of dying parasite is said to be responsible for symptomatic disease. Reactive oxygen species (ROS) that are generated in inflammatory conditions can damage cellular macromolecules such as lipids, DNA, and proteins. The glutathione S-transferases (GSTs) are critical for the protection of cells from ROS. A total of 250 individuals were included in the study: symptomatic NCC = 75, asymptomatic NCC = 75, and healthy controls = 100. The individuals carrying the deletions of GSTM1 and GSTT1 were at risk for NCC (OR = 2.99, 95 %CI = 1.31-6.82, p = 0.0073 and OR = 1.94, 95 %CI = 0.98-3.82, p = 0.0550 respectively). Further, the individuals with these deletions were more likely to develop symptomatic disease (OR = 5.08, 95 % CI = 2.12-12.18, p = 0.0001 for GSTM1 and OR = 3.25, 95 %CI = 1.55-6.82, p = 0.0018 for GSTT1). Genetic variants of GSTM3 and GSTP1 were not associated with NCC. The total GST activity and levels of GSTM1, GSTT1, and GSTM3 were significantly higher in asymptomatic subjects than in symptomatic and healthy controls. Lower GST activity was observed in individuals with GSTM1 and GSTT1 deletions. The present study suggests that the individuals with GSTM1 and GSTT1 deletions are at higher risk to develop symptomatic disease. The higher GST activity and levels of GSTM1, GSTT1, and GSTM3 are likely to play role in maintaining asymptomatic condition.

Entities:  

Keywords:  Glutathione S-transferase; Glutathione S-transferase activity; Neurocysticercosis; Polymorphism; Symptomatic and asymptomatic NCC

Mesh:

Substances:

Year:  2016        PMID: 27021019     DOI: 10.1007/s12035-016-9779-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  46 in total

1.  An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India.

Authors:  Kashi N Prasad; Avantika Verma; Sandeep Srivastava; Rakesh K Gupta; Chandra M Pandey; Vimal K Paliwal
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-20       Impact factor: 2.184

Review 2.  Glutathione S-transferases: biomedical applications.

Authors:  G J Beckett; J D Hayes
Journal:  Adv Clin Chem       Date:  1993       Impact factor: 5.394

3.  A proposal to declare neurocysticercosis an international reportable disease.

Authors:  G Román; J Sotelo; O Del Brutto; A Flisser; M Dumas; N Wadia; D Botero; M Cruz; H Garcia; P R de Bittencourt; L Trelles; C Arriagada; P Lorenzana; T E Nash; A Spina-França
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

4.  Zeta, a novel class of glutathione transferases in a range of species from plants to humans.

Authors:  P G Board; R T Baker; G Chelvanayagam; L S Jermiin
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

5.  TH2 profile in asymptomatic Taenia solium human neurocysticercosis.

Authors:  Anahí Chavarría; Beatrice Roger; Gladis Fragoso; Graciela Tapia; Agnes Fleury; Michel Dumas; Alain Dessein; Carlos Larralde; Edda Sciutto
Journal:  Microbes Infect       Date:  2003-10       Impact factor: 2.700

6.  Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities.

Authors:  J Garcia-Noval; J C Allan; C Fletes; E Moreno; F DeMata; R Torres-Alvarez; H Soto de Alfaro; P Yurrita; H Higueros-Morales; F Mencos; P S Craig
Journal:  Am J Trop Med Hyg       Date:  1996-09       Impact factor: 2.345

7.  A protective effect of glutathione-S-transferase GSTP1*Val(105) against polymorphic light eruption.

Authors:  Thomas P Millard; Anthony A Fryer; Jane M McGregor
Journal:  J Invest Dermatol       Date:  2008-02-21       Impact factor: 8.551

Review 8.  Imaging findings in neurocysticercosis.

Authors:  Héctor H García; Oscar H Del Brutto
Journal:  Acta Trop       Date:  2003-06       Impact factor: 3.112

9.  Glutathione S-transferase P1 Ile105Val polymorphism modulates allergen-induced airway inflammation in human atopic asthmatics in vivo.

Authors:  A Hoskins; P Wu; S Reiss; R Dworski
Journal:  Clin Exp Allergy       Date:  2013-05       Impact factor: 5.018

Review 10.  Human cysticercosis and Indian scenario: a review.

Authors:  Kashi Nath Prasad; Amit Prasad; Avantika Verma; Aloukick Kumar Singh
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

View more
  4 in total

Review 1.  Molecular Neuro-Pathomechanism of Neurocysticercosis: How Host Genetic Factors Influence Disease Susceptibility.

Authors:  Naina Arora; Shweta Tripathi; Reshma Sao; Prosenjit Mondal; Amit Mishra; Amit Prasad
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Differential expression and miRNA regulation of the GSTP1 gene in the regenerating liver of Chiloscyllium plagiosum.

Authors:  Yinghua Ge; Jiewen Zhang; Xinyi Shi; Conger Lu; Lingrong Yang; Yuanyuan Li; Yanna Chen; Dandan Cheng; Jing Bai; Zhengbing Lv; Lili Liu
Journal:  Fish Physiol Biochem       Date:  2017-01-04       Impact factor: 2.794

3.  Long-term and transgenerational phenotypic, transcriptional and metabolic effects in rabbit males born following vitrified embryo transfer.

Authors:  Francisco Marco-Jiménez; José S Vicente; Ximo Garcia-Dominguez; David S Peñaranda; Gianfranco Diretto; Víctor García-Carpintero; Joaquín Cañizares
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

4.  Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host…but Also the Parasite.

Authors:  Andrea Toledo; Rocio Osorio; Carlos Matus; Yazmin Martinez Lopez; Nancy Ramirez Cruz; Edda Sciutto; Gladis Fragoso; Antonio Arauz; Roger Carrillo-Mezo; Agnès Fleury
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.